We analyze Intellectual Ventures' patent portfolio. 33% of IV's assets from their January 2016 public list are gone today. 26% of US issued patents have expired. 10% of IV's issued US patents have sold, 96% went to NPEs, and the rate of sales is accelerating.

We followed up on our 2013 paper investigating Intellectual Venture's patent portfolio to understand what, why and when IV bought, sold and litigated patents. By comparing Intellectual Venture's 2013 assets with its 2016 assets, it is possible to draw conclusions about what you can do to help yourself should IV come knocking.

Our latest paper on Intellectual Ventures has been published in IAM Magazine (Issue #77). We look at how IV's strategy has shifted, how to reduce your risk of exposure to their portfolio, and what the future might hold for them.

In December 2013 Intellectual Ventures (IV) took a step towards transparency by publicly listing about 33,000 of its patent assets, representing 82% of its patent monetization portfolio. Analyzing IV’s portfolio has now become a tractable problem.

In December 2013 Intellectual Ventures (IV) took a step towards transparency by publicly listing about 33,000 of its patent assets, representing 82% of its patent monetization portfolio (http://patents.intven.com/finder). Analyzing IV’s portfolio has now become a tractable problem. Kent Richardson and Erik Oliver penned an article for IAM Magazine that examines what is in the portfolio, what IV buys and what IV did after the purchases.